Picture of Nkarta logo

NKTX — Nkarta News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Nkarta launches $150 mln equity offering after shares soar

** Nkarta Inc's  NKTX.O  slips ~4% in extended trading as co
seeks equity after seeing its stock more than double on Mon
    ** NKTX surged 140.9% to close at $18.72 after co said
experimental cell therapy treatments showed promise in patients
with different blood disorders  urn:newsml:reuters.com:*:nL3N2WN2UV
    ** Co said the drugs, NKX101 and NKX019, were well
tolerated, with no reports of side effects associated with CAR-T
cell therapies, such as cytokine release syndrome or graft
versus host disease
    ** After the bell, co launches $150 mln stock offering for
continued clinical development of the drugs  urn:newsml:reuters.com:*:nGNXwYHjg
    ** Cowen, SVB Securities and Evercore jt bookrunners for
offering, which is slated to price overnight/before the bell
Tues
    ** NKTX has ~33 mln shares outstanding for nearly $620 mln
market cap, per Refinitiv data, and ~29.5 mln of public float

 (Lance Tupper is a Reuters market analyst. The views expressed
are his own)
 ((lance.tupper@thomsonreuters.com
lance.tupper@tr.com 1-332-219-1430))

Recent news on Nkarta

See all news